Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Sino Biopharmaceutical (SBMFF) Expense Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2020-12-31

Income Statement Financials
Revenue	$3.43B
Net Income	$401.53M
Cost of Goods Sold	$750.92M
Gross Profit	$2.68B
Operating Expenses	$2.65B
Operating Income	$773.71M
Non-Operating Income/Expense	$-47.32M
Pre-Tax Income	$726.39M
Normalized Pre-Tax Income	$726.86M
Income after Taxes	$628.96M
Income from Continuous Operations	$628.96M
Consolidated Net Income/Loss	$628.96M
Normalized Income after Taxes	$629.49M
EBIT	$773.71M
EBITDA	$1.00B
Weighted-Average Shares Outstanding (Basic)	18.80B
Weighted-Average Shares Outstanding (Diluted)	18.80B
Earnings per Share (EPS) (Basic)	$0.02
Earnings per Share (EPS) (Diluted)	$0.02
Balance Sheet Financials
Current Assets	$3.30B
Property, Plant, and Equipment	$995.50M
Long-Term Assets	$3.54B
Total Assets	$6.84B
Current Liabilities	$1.59B
Long-Term Debt	$1.86B
Long-Term Liabilities	$2.01B
Total Liabilities	$3.59B
Common Equity	$3.25B
Tangible Shareholders Equity	$3.10B
Shareholders Equity	$3.25B
Common Shares Outstanding	18.86B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$771.64M
Cash Flow from Investing Activities	$-1.14B
Cash Flow from Financial Activities	$323.59M
Beginning Cash	$1.54B
End Cash	$1.54B
Increase/Decrease in Cash	$-1.02M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-393.34M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.64
Gross Margin	78.08%
Operating Margin	22.58%
EBIT Margin	22.58%
EBITDA Margin	29.26%
Pre-Tax Profit Margin	21.20%
Profit Margin	11.72%
Free Cash Flow	$579.92M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.50
Inventory Turnover	2.76
Receiveable Turnover	8.11
Days Sales in Receivables	44.98
Return on Equity	19.36%
Return on Tangible Equity	20.28%
Return on Assets	9.19%
Return on Investments	12.32%
Book Value Per Share	$0.17
Free Cash Flow per Share	$0.03
Operating Cash Flow per Share	$0.04

Data from Zacks Investment Research, Inc.